South Korea
· Delayed Price · Currency is KRW NeoPharm CO., LTD. Statistics
Total Valuation
NeoPharm CO., LTD. has a market cap or net worth of KRW 182.61 billion. The enterprise value is 73.26 billion.
| Market Cap | 182.61B |
| Enterprise Value | 73.26B |
Important Dates
The next estimated earnings date is Friday, November 1, 2024.
| Earnings Date | Nov 1, 2024 |
| Ex-Dividend Date | n/a |
Share Statistics
NeoPharm CO., LTD. has 7.82 million shares outstanding. The number of shares has decreased by -0.01% in one year.
| Shares Outstanding | 7.82M |
| Shares Change (YoY) | -0.01% |
| Shares Change (QoQ) | +0.09% |
| Owned by Insiders (%) | 1.23% |
| Owned by Institutions (%) | 9.77% |
| Float | 4.67M |
Valuation Ratios
The trailing PE ratio is 7.96 and the forward PE ratio is 7.22.
| PE Ratio | 7.96 |
| Forward PE | 7.22 |
| PS Ratio | 1.69 |
| PB Ratio | 1.10 |
| P/FCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
The stock's EV/EBITDA ratio is 2.69, with an EV/FCF ratio of -21.48.
| EV / Earnings | 3.20 |
| EV / Sales | 0.68 |
| EV / EBITDA | 2.69 |
| EV / EBIT | 2.94 |
| EV / FCF | -21.48 |
Financial Position
The company has a current ratio of 8.93, with a Debt / Equity ratio of 0.49.
| Current Ratio | 8.93 |
| Quick Ratio | 7.99 |
| Debt / Equity | 0.49 |
| Debt / EBITDA | 0.03 |
| Debt / FCF | -0.24 |
| Interest Coverage | 666.42 |
Financial Efficiency
Return on equity (ROE) is 14.55% and return on invested capital (ROIC) is 9.84%.
| Return on Equity (ROE) | 14.55% |
| Return on Assets (ROA) | 9.05% |
| Return on Capital (ROIC) | 9.84% |
| Revenue Per Employee | 627.08M |
| Profits Per Employee | 133.31M |
| Employee Count | 172 |
| Asset Turnover | 0.63 |
| Inventory Turnover | 3.79 |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -11.03% in the last 52 weeks.
| Beta (5Y) | n/a |
| 52-Week Price Change | -11.03% |
| 50-Day Moving Average | 24,022.00 |
| 200-Day Moving Average | 25,614.75 |
| Relative Strength Index (RSI) | 57.39 |
| Average Volume (20 Days) | 63,068 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, NeoPharm CO., LTD. had revenue of KRW 107.86 billion and earned 22.93 billion in profits. Earnings per share was 2,931.92.
| Revenue | 107.86B |
| Gross Profit | 66.64B |
| Operating Income | 24.89B |
| Pretax Income | 29.06B |
| Net Income | 22.93B |
| EBITDA | 27.23B |
| EBIT | 24.89B |
| Earnings Per Share (EPS) | 2,931.92 |
Balance Sheet
The company has 110.16 billion in cash and 812.24 million in debt, giving a net cash position of 109.35 billion or 13,982.43 per share.
| Cash & Cash Equivalents | 110.16B |
| Total Debt | 812.24M |
| Net Cash | 109.35B |
| Net Cash Per Share | 13,982.43 |
| Equity (Book Value) | 166.08B |
| Book Value Per Share | 21,236.68 |
| Working Capital | 123.46B |
Cash Flow
In the last 12 months, operating cash flow was 17.68 billion and capital expenditures -21.09 billion, giving a free cash flow of -3.41 billion.
| Operating Cash Flow | 17.68B |
| Capital Expenditures | -21.09B |
| Free Cash Flow | -3.41B |
| FCF Per Share | -436.07 |
Margins
Gross margin is 61.79%, with operating and profit margins of 23.08% and 21.26%.
| Gross Margin | 61.79% |
| Operating Margin | 23.08% |
| Pretax Margin | 26.94% |
| Profit Margin | 21.26% |
| EBITDA Margin | 25.25% |
| EBIT Margin | 23.08% |
| FCF Margin | -3.16% |
Dividends & Yields
This stock pays an annual dividend of 750.00, which amounts to a dividend yield of 3.23%.
| Dividend Per Share | 750.00 |
| Dividend Yield | 3.23% |
| Dividend Growth (YoY) | 7.14% |
| Years of Dividend Growth | 1 |
| Payout Ratio | 25.58% |
| Buyback Yield | 0.01% |
| Shareholder Yield | 3.24% |
| Earnings Yield | 12.56% |
| FCF Yield | -1.87% |
Stock Splits
The last stock split was on June 12, 2008. It was a forward split with a ratio of 1.3.
| Last Split Date | Jun 12, 2008 |
| Split Type | Forward |
| Split Ratio | 1.3 |